OI
WST icon

Oakbrook Investments’s West Pharmaceutical WST Stock Holding History

Oakbrook Investments’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-6,650
Closed -$1M – 521
2019
Q4 		$1M Sell
6,650
-1,350
-17% -$197K 0.2% 126
2019
Q3 		$1.14M Sell
8,000
-850
-10% -$117K 0.07% 207
2019
Q2 		$1.11M Buy
8,850
+675
+8% +$79.7K 0.07% 239
2019
Q1 		$901K Buy
8,175
+2,500
+44% +$260K 0.05% 269
2018
Q4 		$556K Buy
5,675
+900
+19% +$97.7K 0.04% 347
2018
Q3 		$590K Buy
4,775
+1,250
+35% +$140K 0.03% 411
2018
Q2 		$350K Sell
3,525
-3,565
-50% -$328K 0.02% 427
2018
Q1 		$626K Buy
+7,090
New +$663K 0.04% 306
2017
Q4 		– Sell
-5,400
Closed -$520K – 625
2017
Q3 		$520K Sell
5,400
-50
-0.9% -$4.52K 0.03% 330
2017
Q2 		$515K Buy
5,450
+2,090
+62% +$192K 0.03% 318
2017
Q1 		$274K Sell
3,360
-3,940
-54% -$329K 0.02% 448
2016
Q4 		$619K Sell
7,300
-100
-1% -$7.86K 0.04% 315
2016
Q3 		$551K Buy
+7,400
New +$587K 0.03% 344

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Oakbrook Investments's WST Position: Q1 2020 in Review

Oakbrook Investments sold out of West Pharmaceutical (WST) in Q1 2020, closing a stake of 6,650 shares — an estimated $1M sold.

Oakbrook Investments first reported a position in WST in Q3 2016 and held it in 13 quarters. The position peaked at $1.14M in Q3 2019. 468 funds tracked by Wall St. Rank hold WST as of Q1 2020.

  • Oakbrook Investments reported no remaining West Pharmaceutical position as of Q1 2020 after selling out during the quarter.
  • Oakbrook Investments sold 6,650 West Pharmaceutical shares in Q1 2020, an estimated $1M.
  • Oakbrook Investments first reported a position in West Pharmaceutical in Q3 2016 and held it in 13 quarters.
  • Oakbrook Investments's West Pharmaceutical position peaked at $1.14M in Q3 2019.
  • 468 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2020.

Based on Oakbrook Investments's 13F filing for Q1 2020, filed 22 Apr 2020.